Click here - to use the wp menu builder

Certara Appoints Dr. William F. Feehery as Chief Executive Officer

PRINCETON, N.J.–(BUSINESS WIRE)–Certara announced today that it has appointed Dr. William F. Feehery as its new CEO and a member of the Certara Board of Directors….

http://www.businesswire.com/news/home/20190516005100/en/Certara-Appoints-Dr.-William-F.-Feehery-Chief

Certara Appoints Dr. William F. Feehery as Chief Executive Officer

Recent Articles

Lilly to Supply the EU and EEA with up to 220,000 Doses of AbCellera-Discovered Bamlanivimab Together with Etesevimab for the Treatment of Confirmed COVID-19

Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream, a Topical JAK Inhibitor, for the Treatment of Atopic Dermatitis (AD)

bluebird bio Submits Biologics License Application (BLA) to FDA for betibeglogene autotemcel (beti-cel) Gene Therapy for Patients With β-thalassemia Who Require Regular Red Blood...

LabGenius Appoints Dr. Didier Landais as Chief Operating Officer

Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries